{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T03:00:21Z","timestamp":1777950021645,"version":"3.51.4"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2022YFS0622"],"award-info":[{"award-number":["2022YFS0622"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Mucopolysaccharidosis type II (MPS II) is an X-linked recessive lysosomal storage metabolic disorder caused by pathogenic mutations in the iduronate-2-sulfatase (IDS) gene. Herein, we report the case of a 2-year-old male patient diagnosed with concurrent Evans syndrome (ES) and MPS II, who presented with severe anemia, thrombocytopenia, recurrent respiratory tract infections, and typical clinical manifestations of MPS II. Laboratory examinations showed decreased hemoglobin (Hb) and platelet (PLT) counts, a positive direct Coombs test, presence of anti-platelet antibodies, elevated urinary glycosaminoglycan levels, and complete absence of IDS enzyme activity. Whole exome sequencing identified a novel compound heterozygous nonsense mutation in the IDS gene: c.380_383dup GCTA, p.Y128X. The patient received hematopoietic stem cell transplantation (HSCT) and underwent long-term follow-up. During the follow-up period, the patient's IDS enzyme activity returned to normal levels, and no further recurrence of ES was observed. This study reports a novel pathogenic mutation of the IDS gene, and represents the first documented case of concurrent ES and MPS II in a toddler. HSCT has been confirmed to be an effective therapeutic strategy for this extremely rare comorbid condition. Additionally, we discuss the potential pathogenic association between mucopolysaccharidosis (MPS) and ES, and present a systematic summary of the clinical management of this patient, to provide a reference for improved identification and treatment of similar clinical cases in the future.<\/jats:p>","DOI":"10.3389\/fped.2026.1784387","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:34:22Z","timestamp":1777872862000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Merging evans syndrome with mucopolysaccharidosis type II: a case report"],"prefix":"10.3389","volume":"14","author":[{"given":"Xinrui","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Children Hematological Oncology and Birth Defects Laboratory, The Affiliated Hospital of Southwest Medical University, Sichuan Clinical Research Center for Birth Defects","place":["Luzhou, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children Hematological Oncology and Birth Defects Laboratory, The Affiliated Hospital of Southwest Medical University, Sichuan Clinical Research Center for Birth Defects","place":["Luzhou, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhui","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Growth and Health Care, The Guangan People\u2019s Hospital","place":["Guangan, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children Hematological Oncology and Birth Defects Laboratory, The Affiliated Hospital of Southwest Medical University, Sichuan Clinical Research Center for Birth Defects","place":["Luzhou, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Affiliated Hospital of Southwest Medical University","place":["Luzhou, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children Hematological Oncology and Birth Defects Laboratory, The Affiliated Hospital of Southwest Medical University, Sichuan Clinical Research Center for Birth Defects","place":["Luzhou, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongying","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children Hematological Oncology and Birth Defects Laboratory, The Affiliated Hospital of Southwest Medical University, Sichuan Clinical Research Center for Birth Defects","place":["Luzhou, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/diagnostics10020063","article-title":"Respiratory dysfunction in children and adolescents with mucopolysaccharidosis types I, II, IVA, and VI","volume":"10","author":"Tulebayeva","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1177\/003591571701001833","article-title":"A rare disease in two brothers","volume":"10","author":"Hunter","year":"1917","journal-title":"Proc R Soc Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/bs.accb.2019.09.001","article-title":"Mucopolysaccharidosis type II (hunter syndrome): clinical and biochemical aspects of the disease and approaches to its diagnosis and treatment","volume":"77","author":"Mohamed","year":"2020","journal-title":"Adv Carbohydr Chem Biochem"},{"key":"B4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13023-021-01743-2","article-title":"Natural progression of cardiac features and long-term effects of enzyme replacement therapy in Taiwanese patients with mucopolysaccharidosis II","volume":"16","author":"Lin","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12920-021-01027-5","article-title":"Detailed pedigree analyses and prenatal diagnosis for a family with mucopolysaccharidosis type II","volume":"14","author":"Zhang","year":"2021","journal-title":"BMC Med Genomics"},{"key":"B6","doi-asserted-by":"publisher","first-page":"103639","DOI":"10.1016\/j.scr.2024.103639","article-title":"Human induced pluripotent stem cell line (PNUSCRi005-A) generated from severe type of hunter syndrome patient carrying exonic deletion (exon 4-7 del) in in human iduronate 2-sulfatase gene","volume":"83","author":"Lee","year":"2025","journal-title":"Stem Cell Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.3390\/ijms21041258","article-title":"Mucopolysaccharidosis type II: one hundred years of research, diagnosis, and treatment","volume":"21","author":"D'Avanzo","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"104447","DOI":"10.1016\/j.ejmg.2022.104447","article-title":"Genotype-phenotype spectrum of 130 unrelated Indian families with mucopolysaccharidosis type II","volume":"65","author":"Agrawal","year":"2022","journal-title":"Eur J Med Genet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1103620","DOI":"10.3389\/fgene.2023.1103620","article-title":"Phenotypic and genetic characteristics of 130 patients with mucopolysaccharidosis type II: a single-center retrospective study in China","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Genet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/bjh.19073","article-title":"Paediatric-onset evans syndrome: breaking away from refractory immune thrombocytopenia","volume":"203","author":"Aladjidi","year":"2023","journal-title":"Br J Haematol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s13052-024-01769-9","article-title":"The diagnosis and management of mucopolysaccharidosis type II","volume":"50","author":"Mao","year":"2024","journal-title":"Ital J Pediatr"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.3390\/brainsci14111085","article-title":"Otorhinolaryngological problems in mucopolysaccharidoses: a review of common symptoms in a rare disease","volume":"14","author":"Wa\u015bniewska-W\u0142odarczyk","year":"2024","journal-title":"Brain Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.ajhg.2009.07.011","article-title":"IDS Crossing of the blood-brain barrier corrects CNS defects in MPSII mice","volume":"85","author":"Polito","year":"2009","journal-title":"Am J Hum Genet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"101127","DOI":"10.1016\/j.omtm.2023.101127","article-title":"Sustained long-term disease correction in a murine model of MPSII following stem cell gene therapy","volume":"31","author":"Ellison","year":"2023","journal-title":"Mol Ther Methods Clin Dev"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/sj.bmt.1702398","article-title":"Hematopoietic cell transplantation for mucopolysaccharidosis IIB (hunter syndrome)","volume":"25","author":"Peters","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"B16","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00277-011-1248-6","article-title":"Hunter syndrome and new onset idiopathic thrombocytopenic purpura in a young patient","volume":"91","author":"Uz","year":"2012","journal-title":"Ann Hematol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2147\/TCRM.S462996","article-title":"The etiologic landscape of lymphoproliferation in childhood: proposal for a diagnostic approach exploring from infections to inborn errors of immunity and metabolic diseases","volume":"20","author":"Costagliola","year":"2024","journal-title":"Ther Clin Risk Manag"},{"key":"B18","doi-asserted-by":"publisher","first-page":"245","DOI":"10.5858\/arpa.2018-0190-RS","article-title":"Autoimmune lymphoproliferative syndrome: an overview","volume":"144","author":"Matson","year":"2020","journal-title":"Arch Pathol Lab Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1080\/1744666X.2021.1978842","article-title":"Presentation and diagnosis of autoimmune lymphoproliferative syndrome (ALPS)","volume":"17","author":"Lambert","year":"2021","journal-title":"Expert Rev Clin Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.1016\/S2352-3026(23)00362-9","article-title":"Diagnostic evaluation of paediatric autoimmune lymphoproliferative immunodeficiencies (ALPID): a prospective cohort study","volume":"11","author":"H\u00e4gele","year":"2024","journal-title":"Lancet Haematol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40348-023-00167-1","article-title":"Autoimmune lymphoproliferative immunodeficiencies (ALPID) in childhood: breakdown of immune homeostasis and immune dysregulation","volume":"10","author":"Toskov","year":"2023","journal-title":"Mol Cell Pediatr"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1016\/j.jaip.2020.06.065","article-title":"Defective FAS-mediated apoptosis and immune dysregulation in Gaucher disease","volume":"8","author":"Miano","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1182\/blood-2009-08-239525","article-title":"Identifying autoimmune lymphoproliferative syndrome in children with evans syndrome: a multi-institutional study","volume":"115","author":"Seif","year":"2010","journal-title":"Blood"},{"key":"B24","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/jnc.13138","article-title":"Immune dysfunction in niemann-pick disease type C","volume":"136","author":"Platt","year":"2016","journal-title":"J Neurochem"},{"key":"B25","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41586-021-03762-2","article-title":"Tonic prime-boost of STING signalling mediates niemann-pick disease type C","volume":"596","author":"Chu","year":"2021","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","first-page":"12252","DOI":"10.3390\/ijms252212252","article-title":"Complement system and adhesion molecule skirmishes in fabry disease: insights into pathogenesis and disease mechanisms","volume":"25","author":"Magnusen","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1177\/0960327110379023","article-title":"Thrombocytopenia associated with galsulfase treatment","volume":"30","author":"Do\u011fan","year":"2011","journal-title":"Hum Exp Toxicol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e226518","DOI":"10.1136\/bcr-2018-226518","article-title":"Hunter syndrome with persistent thrombocytopenia","volume":"12","author":"Panigrahi","year":"2019","journal-title":"BMJ Case Rep"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.3390\/biom12091313","article-title":"Glycosylation-The most diverse post-translational modification","volume":"12","author":"Staudacher","year":"2022","journal-title":"Biomolecules"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-030-70115-4_1","article-title":"N-Glycosylation","volume":"1325","author":"Hirata","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"6446","DOI":"10.1039\/D5OB00699F","article-title":"Efficient synthesis of fluorogenic substrates for mucopolysaccharidosis (MPS) IIIA and IIIB via aromatic \u03b1-glycosylation with thioglycosyl donors","volume":"23","author":"Pan","year":"2025","journal-title":"Org Biomol Chem"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1784387\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:34:23Z","timestamp":1777872863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1784387\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":31,"alternative-id":["10.3389\/fped.2026.1784387"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1784387","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"article-number":"1784387"}}